The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...
The US Food and Drug Administration (FDA) has approved Janssen Therapeutics' NS3/4A protease inhibitor 'Olysio (simeprevir)' for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with ...
US-based pharmaceutical firm Merck has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for its investigational oral combination regimen MK-5172/MK-8742 for the treatment of chronic hepatitis C virus ...
Indian auto maker Tata Motors has reported total sales of 49,611 vehicles including exports, commercial and passenger vehicles during August 2013. During the month, the company sold a total 44,717 vehicles in the domestic market that ...
Tags: auto maker, Tata Motors, commercial vehicles
Abbott has introduced FDA-approved hepatitis C virus (HCV) genotyping test for patients in the US. The completely automated RealTime HCV Genotype II test determines the specific type or strain of the HCV virus present in the blood of an ...
Tags: US, Health&Medicine, Abbott
Laboratory Corporation of America Holdings (LabCorp) has become the first clinical reference laboratory to offer Roche COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0, a viral load assay for hepatitis C virus. Designed with enhanced ...
Biopharmaceutical company Gilead Sciences has obtained priority review status for Sofosbuvir new drug application (NDA) from the FDA for the treatment of hepatitis C infection (HCV). The investigational product is an oral nucleotide ...
Tags: Gilead, Sofosbuvir NDA
Advanced Biological Laboratories (ABL) has acquired all the assets of Evivar Medical (Evivar), which includes its Hepatitis B virus (HBV) and C (HCV) web-based decision support tools and the associated viral genome analysis systems (SeqHepB ...
Wärtsilä, the marine industry's leading solutions and services provider, has been contracted to provide the design for a large heavy construction vessel (HCV). The ship is to be built for Subsea 7 S.A., the seabed-to-surface ...
Tags: Transportation, Service, Design
Indian auto maker Tata Motors has reported total sales of 49,304 vehicles including exports, commercial and passenger vehicles during May 2013. During the month, the company sold a total 45,430 vehicles in the domestic market that ...
Tags: Tata Motors, auto
Indian auto maker Tata Motors has reported total sales of 72,712 vehicles including exports, commercial and passenger vehicles in March 2013. The company sold a total 56,813 commercial vehicles in the domestic market for the month, ...
Tags: Tata Motors, Vehicles
US-based biopharmaceutical company Spring Bank Pharmaceuticals has closed a $10.5m Series A financing round from Brock Securities with Gilford Securities as a participator. The firm is planning to invest the fund in its Phase I clinical ...
Santaris Pharma and miRagen Therapeutics have extended their research deal to discover and develop LNA-drugs against disease causing microRNAs. The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field ...
Inovia Pharmaceuticals will move its hepatitis C DNA vaccine into a phase 1/11a clinical trial by the end of 2013. The advancement of this work is based on exceptional results of a preclinical study, which showed for the first time that a ...
Tags: Inovia Pharmaceuticals, hepatitis C DNA vaccine, clinical trial, 2013
TATA Motors' total sales of TATA commercial and passenger vehicles in December 2012 were 65,582 vehicles. The company's domestic sales of TATA commercial and passenger vehicles for December 2012 were 61,700 nos. Cumulative sales for ...
Tags: TATA Motors, passenger vehicle, commercial vehicle, auto industry